EPISODE · Sep 18, 2024 · 29 MIN
The Building Blocks of What's Possible with David Butler, Ph.D.
from Patient Empowerment Program: A Rare Disease Podcast
Hongene Biotech is a producer of RNA building blocks – the first step for what’s possible in RNA drug-discovery and development. David Butler, Ph.D., Chief Technology Officer of Hongene, joins the Patient Empowerment Program to discuss why Hongene aims to help make RNA medicines accessible and affordable for patients everywhere, regardless of prevalence. On this episode we discuss: 2:40 Hongene Biotech and what do they do 8:09 The early days of nucleoside building blocks and maturation of Hongene 12:00 Hongene is a strong supporter of n-Lorem. Why? 15:30 David’s origins in the chemistry field 17:38 Incremental progress that has been made in science and manufacturing Links: 2024 Colloquium - https://www.nlorem.org/nano-rare-patient-colloquium-2024/ Make Hope Possible with a Donation - https://www.nlorem.org/donate/ Hongene - https://www.hongene.com/
What this episode covers
Hongene Biotech is a producer of RNA building blocks – the first step for what’s possible in RNA drug-discovery and development. David Butler, Ph.D., Chief Technology Officer of Hongene, joins the Patient Empowerment Program to discuss why Hongene aims to help make RNA medicines accessible and affordable for patients everywhere, regardless of prevalence. On this episode we discuss: 2:40 Hongene Biotech and what do they do 8:09 The early days of nucleoside building blocks and maturation of Hongene 12:00 Hongene is a strong supporter of n-Lorem. Why? 15:30 David’s origins in the chemistry field 17:38 Incremental progress that has been made in science and manufacturing Links: 2024 Colloquium - https://www.nlorem.org/nano-rare-patient-colloquium-2024/ Make Hope Possible with a Donation - https://www.nlorem.org/donate/ Hongene - https://www.hongene.com/
NOW PLAYING
The Building Blocks of What's Possible with David Butler, Ph.D.
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m